Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis—A Six-Month Follow-up Study in Patients Treated with Pirfenidone

The mechanism of action of pirfenidone in idiopathic pulmonary fibrosis (IPF) has not been fully elucidated. To offer additional insight, we evaluated the change in the cytokine profile in exhaled breath condensate (EBC) following a six-month treatment with pirfenidone in patients with IPF. EBC conc...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med
Main Authors: Jaskiewicz, Kaja, Mycroft, Katarzyna, Maskey-Warzechowska, Marta, Paralusz, Karolina, Siemiez, Natalia, Nejman-Gryz, Patrycja, Barnas, Malgorzata, Krenke, Rafal, Gorska, Katarzyna
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465603/
https://ncbi.nlm.nih.gov/pubmed/32764328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082523
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items